Seeking Alpha

FDA denies Amarin's ANCHOR SPA appeal

  • The FDA has not accepted Amarin's (AMRN) appeal regarding the rescission of the SPA for Vascepa's ANCHOR study.
  • The company also says its "request for a meeting at a high level within the FDA regarding the appeal was not granted."
  • AMRN says it plans to continue to pursue the appeal. (8-K)
  • AMRN -12% premarket
Comments (6)
  • mangum
    , contributor
    Comments (63) | Send Message
     
    FDA, bought and paid for, just like every other corner of the Obama Carnival.
    22 Nov 2013, 07:46 AM Reply Like
  • SimonSaysShort
    , contributor
    Comments (98) | Send Message
     
    Nice! Blame Obama this time...that is a new angle for AMRN longs...
    22 Nov 2013, 08:02 AM Reply Like
  • Quoth the Raven
    , contributor
    Comments (1820) | Send Message
     
    Saw that one coming, a MILE away :
    http://seekingalpha.co...
    22 Nov 2013, 08:01 AM Reply Like
  • voltnfan
    , contributor
    Comments (7) | Send Message
     
    No other company generates more bad news than Amarin. It never ends! But Joe Z continues to give himself pay increases! Amazing!
    22 Nov 2013, 08:17 AM Reply Like
  • tonyeg
    , contributor
    Comments (145) | Send Message
     
    I became concerned when JZ only bought +50k shares at $1.86...not a lot of conviction.
    22 Nov 2013, 08:17 PM Reply Like
  • suren037
    , contributor
    Comments (6) | Send Message
     
    the decision on 20th Dec is already out it seems: Screw AMRN .
    24 Nov 2013, 04:40 AM Reply Like
DJIA (DIA) S&P 500 (SPY)